News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
TANEN DAVID M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/29/2022 |
4
| TANEN DAVID M (Director) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 34,000 options to buy
@ $3.53, valued at
$120k
|
|
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2020 |
4
| TANEN DAVID M (Director) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Converted 231,553 shares
@ $0
Converted 233,405 shares
@ $0
Converted 68,831 shares
@ $0
Converted 37,119 shares
@ $16.15, valued at
$599.5k
Converted 219,482 options to buy
@ $0
Converted 221,237 options to buy
@ $0
Converted 65,243 preferred shares
@ $0
Converted convertible notes
@ $16.15, valued at
$0 |
|
| 10/05/2016 |
4
| TANEN DAVID M (Secretary) has filed a Form 4 on Arno Therapeutics, Inc |
| 04/11/2016 |
4
| TANEN DAVID M (Secretary) has filed a Form 4 on Arno Therapeutics, Inc|
Txns:
| Granted 88,628 options to buy
@ $0.37, valued at
$32.8k
|
|
| 01/14/2016 |
4
| TANEN DAVID M (Secretary) has filed a Form 4 on Arno Therapeutics, Inc|
Txns:
| Bought 362,015 shares
@ $0.35, valued at
$126.7k
|
|
| 01/28/2014 |
4
| TANEN DAVID M (Secretary) has filed a Form 4 on Arno Therapeutics, Inc|
Txns:
| Granted 34,224 options to buy
@ $2.9, valued at
$99.2k
|
|
| 11/06/2013 |
4
| TANEN DAVID M (Secretary) has filed a Form 4 on Arno Therapeutics, Inc|
Txns:
| Granted 68,448 options to buy
@ $2.4, valued at
$164.3k
|
|
| 07/23/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/16/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 12/23/2008 |
4
| TANEN DAVID M (Director) has filed a Form 4 on Nile Therapeutics, Inc. |
| 12/16/2008 |
4
| TANEN DAVID M (Director) has filed a Form 4 on Nile Therapeutics, Inc. |
| 12/15/2008 |
4
| TANEN DAVID M (Director) has filed a Form 4 on Nile Therapeutics, Inc. |
| 12/12/2008 |
4
| TANEN DAVID M (Director) has filed a Form 4 on Nile Therapeutics, Inc. |
|
|